This is one of those small-but-surprisingly-divisive questions in baby immunisation clinics: should Rotarix be given before the injectable vaccines, or after them?

Ask around and you will hear two schools of thought. One is that oral rotavirus vaccine should come first. The other is that it should be left until after the injections, sometimes with the argument that the baby may “calm down” afterwards and take it more easily. In practice, many clinicians are doing what they were taught locally rather than what is actually written in guidance.

So what does the literature say?

First, the reassuring bit: I could not find evidence that giving Rotarix before rather than after the injectable vaccines changes its efficacy in any meaningful way. The main immunogenicity studies look at co-administration with routine infant vaccines, rather than sequence. These studies show that Rotarix is immunogenic and well tolerated when given alongside the usual childhood vaccines, and that co-administration does not appear to impair the immune responses to those injected vaccines. In other words, from an effectiveness point of view, the important thing is that the child receives the vaccine appropriately within schedule, not that there is some magic sequence that makes it “work better.”

However, when we move away from pure efficacy and look at practicalities and infant distress, the picture becomes more interesting.

Current UK operational guidance leans toward giving Rotarix first. The 2025 NHS England PGD (at time of writing) says to consider giving the oral rotavirus vaccine before administration of any vaccine injections which may unsettle the infant. Earlier UK PGDs say the same. WHO (p3) also states that oral rotavirus vaccines may be given simultaneously with routine childhood vaccines and notes that, because they have a pain-mitigating effect due to their sucrose content, it is useful to give them before co-administered injectable vaccines.

That practical recommendation is backed up by some trial evidence. A randomised trial published in Vaccine in 2015 found that giving rotavirus vaccine first did not differ from sucrose solution in reducing injection pain (equally successful), and the authors recommended administering rotavirus vaccine prior to injectable vaccines. A later randomised study found that infants receiving rotavirus vaccine before injections had better pain reduction than those receiving it after injections.

That makes sense clinically. If Rotarix is given first, the sweet oral vaccine may offer a small analgesic effect before the needles. It is also often easier to administer an oral vaccine to a settled infant than to one who is already crying hard after two or three injections. Anyone who has tried to get a very upset baby to keep an oral vaccine in their mouth will know this is not just a theoretical point.

Of course, some clinicians still prefer leaving it until the end, often because they feel the baby may settle in a cuddle and then take it. That may occasionally work in an individual case, but it is not the direction the guidance points us in, and it is not where the limited sequence evidence points either.

So where do I land on it? My view is leaning towards give Rotarix first where possible. Not because there is strong evidence that it improves vaccine efficacy, but because guidance supports it, the pain literature modestly supports it, and it is often the more practical option in a busy clinic. It also reduces the risk of ending up with an upset infant who is more likely to spit part of the dose back out.

That said, I would not overstate this into a “must never be given after injections” rule. If Rotarix is given after the injectables and the infant receives the dose successfully, there is no good evidence that the vaccine has somehow been compromised simply because of the order. The real priority is successful administration within the age limits and schedule.

Sometimes these clinic debates sound bigger than they are. On balance, the literature and current guidance favour Rotarix as a starter rather than a dessert. But if it ends up a dessert, so be it. There is nothing suggesting that this is categorically wrong. This one is probably best framed as a practical preference rather than an efficacy-critical rule.

References

• NHS England. Rotavirus PGD v7.0. Valid from 30 June 2025.

• NHS England. Rotavirus PGD v6.00. Valid from 30 June 2023.

• WHO. Summary of the WHO position paper on rotavirus vaccines. 2021.

• Vesikari T, et al. Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe. Vaccine. 2010.

• Taddio A, et al. A randomized trial of rotavirus vaccine versus sucrose solution for vaccine injection pain. Vaccine. 2015.

• Yin HC, et al. Comparison of iatrogenic pain between rotavirus vaccination before and after vaccine injection in 2-month-old infants. Hum Vaccin Immunother. 2017.

• Rotarix SmPC. Electronic Medicines Compendium.